Manuela Durando1, Lucas Gennaro2, Gene Y Cho3, Dilip D Giri4, Merlin M Gnanasigamani5, Sujata Patil6, Elizabeth J Sutton7, Joseph O Deasy8, Elizabeth A Morris9, Sunitha B Thakur10. 1. Department of Diagnostic Imaging and Radiotherapy, A. O. U. Città della Salute e della Scienza of Turin, 10126, Italy. Electronic address: mdurando@inwind.it. 2. Department of Radiology, Memorial Sloan-Kettering Cancer Center, 300 East, 66th street, NY 10065, USA. Electronic address: gennarol@mskcc.org. 3. Department of Radiology, Memorial Sloan-Kettering Cancer Center, 300 East, 66th street, NY 10065, USA. Electronic address: chog@mskcc.org. 4. Department of Pathology, Memorial Sloan-Kettering Cancer Center, 300 East 66th street, NY 10065, USA. Electronic address: girid@mskcc.org. 5. Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, NY 10065, USA. Electronic address: merlinmargaret@gmail.com. 6. Department of Biostatistics, Memorial Sloan-Kettering Cancer Center, 485 Lexington Avenue, NY 10065, USA. Electronic address: patils@mskcc.org. 7. Department of Radiology, Memorial Sloan-Kettering Cancer Center, 300 East, 66th street, NY 10065, USA. Electronic address: suttone@mskcc.org. 8. Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, NY 10065, USA. Electronic address: deasyj@mskcc.org. 9. Department of Radiology, Memorial Sloan-Kettering Cancer Center, 300 East, 66th street, NY 10065, USA. Electronic address: morrise@mskcc.org. 10. Department of Radiology, Memorial Sloan-Kettering Cancer Center, 300 East, 66th street, NY 10065, USA; Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, NY 10065, USA. Electronic address: thakurs@mskcc.org.
Abstract
PURPOSE: To assess the association between apparent diffusion coefficient (ADC), and histological prognostic parameters in malignant breast lesions. The ability of ADC to identify lesions with the presence of Lymphovascular invasion (LVI) in breast carcinoma was also examined. MATERIALS AND METHODS: This HIPAA-compliant retrospective study consisted of 212 consecutive patients with known cancers who underwent 3.0T MRI between January 2011 and 2013. In this study, a total of 126 malignant lesions in 114 women, who had undergone DWI (b-values of 0 and 1000s/mm(2)) in addition to diagnostic MRI, were included. Patients with less than 0.8cm lesions, or those who underwent neoadjuvant chemotherapy or suboptimal DW images were excluded. Classical prognostic factors [lesion size, histopathological type and grade, lymph node (LN) status and lymphovascular invasion (LVI)], molecular prognostic markers [estrogen receptor (ER), progesterone receptor (PR) and human epidermal grow factor receptor 2 (HER2)] were reviewed and recorded. A region of interest (ROI) was drawn within the lesions to measure ADC values. Statistical analyses were performed by the Wilcoxon rank sum test (statistical significance at P<0.05). Adjusted p values from multiple comparison analysis were also calculated. RESULTS: This study demonstrates an inverse correlation between ADC and LVI in malignant lesions and the ability of ADC to identify aggressiveness in lesions with positive LVI. Tumor size, grade, ER, PR, HER2 and lymph node status did not impact tumor ADC value. However, tumors with LVI showed significantly lower ADC values when compared to tumors without LVI, regardless of the enhancement type, histological grade, histological type, and LN status. CONCLUSION: Our study shows that ADC could be a potential clinical adjunct in the evaluation of prognostic factors related to malignant lesion aggressiveness such as LVI.
PURPOSE: To assess the association between apparent diffusion coefficient (ADC), and histological prognostic parameters in malignant breast lesions. The ability of ADC to identify lesions with the presence of Lymphovascular invasion (LVI) in breast carcinoma was also examined. MATERIALS AND METHODS: This HIPAA-compliant retrospective study consisted of 212 consecutive patients with known cancers who underwent 3.0T MRI between January 2011 and 2013. In this study, a total of 126 malignant lesions in 114 women, who had undergone DWI (b-values of 0 and 1000s/mm(2)) in addition to diagnostic MRI, were included. Patients with less than 0.8cm lesions, or those who underwent neoadjuvant chemotherapy or suboptimal DW images were excluded. Classical prognostic factors [lesion size, histopathological type and grade, lymph node (LN) status and lymphovascular invasion (LVI)], molecular prognostic markers [estrogen receptor (ER), progesterone receptor (PR) and human epidermal grow factor receptor 2 (HER2)] were reviewed and recorded. A region of interest (ROI) was drawn within the lesions to measure ADC values. Statistical analyses were performed by the Wilcoxon rank sum test (statistical significance at P<0.05). Adjusted p values from multiple comparison analysis were also calculated. RESULTS: This study demonstrates an inverse correlation between ADC and LVI in malignant lesions and the ability of ADC to identify aggressiveness in lesions with positive LVI. Tumor size, grade, ER, PR, HER2 and lymph node status did not impact tumor ADC value. However, tumors with LVI showed significantly lower ADC values when compared to tumors without LVI, regardless of the enhancement type, histological grade, histological type, and LN status. CONCLUSION: Our study shows that ADC could be a potential clinical adjunct in the evaluation of prognostic factors related to malignant lesion aggressiveness such as LVI.
Authors: M Costantini; P Belli; P Rinaldi; E Bufi; G Giardina; G Franceschini; G Petrone; L Bonomo Journal: Clin Radiol Date: 2010-09-24 Impact factor: 2.350
Authors: A H S Lee; S E Pinder; R D Macmillan; M Mitchell; I O Ellis; C W Elston; R W Blamey Journal: Eur J Cancer Date: 2005-12-27 Impact factor: 9.162
Authors: Savannah C Partridge; Christiane D Mullins; Brenda F Kurland; Michael D Allain; Wendy B DeMartini; Peter R Eby; Constance D Lehman Journal: AJR Am J Roentgenol Date: 2010-06 Impact factor: 3.959
Authors: Riham H Ei Khouli; Michael A Jacobs; Sarah D Mezban; Peng Huang; Ihab R Kamel; Katarzyna J Macura; David A Bluemke Journal: Radiology Date: 2010-07 Impact factor: 11.105
Authors: Nathan S White; Carrie McDonald; Carrie R McDonald; Niky Farid; Josh Kuperman; David Karow; Natalie M Schenker-Ahmed; Hauke Bartsch; Rebecca Rakow-Penner; Dominic Holland; Ahmed Shabaik; Atle Bjørnerud; Tuva Hope; Jona Hattangadi-Gluth; Michael Liss; J Kellogg Parsons; Clark C Chen; Steve Raman; Daniel Margolis; Robert E Reiter; Leonard Marks; Santosh Kesari; Arno J Mundt; Christopher J Kane; Christopher J Kaine; Bob S Carter; William G Bradley; Anders M Dale Journal: Cancer Res Date: 2014-09-01 Impact factor: 12.701
Authors: D Leithner; G J Wengert; T H Helbich; S Thakur; R E Ochoa-Albiztegui; E A Morris; K Pinker Journal: Clin Radiol Date: 2017-12-09 Impact factor: 2.350
Authors: R Rathore; A Parihar; D K Dwivedi; A K Dwivedi; N Kohli; R K Garg; A Chandra Journal: AJNR Am J Neuroradiol Date: 2017-10-12 Impact factor: 3.825
Authors: Piotr Andrzejewski; Georg Wengert; Thomas H Helbich; Heinrich Magometschnigg; Dietmar Georg; Marcus Hacker; Pascal Baltzer; Paola Clauser; Panagiotis Kapetas; Petra Georg; Wolfgang Wadsak; Katja Pinker Journal: Contrast Media Mol Imaging Date: 2019-01-08 Impact factor: 3.161